XRP Healthcare M&A Holding Inc. is a Dubai-based healthcare acquisition and technology company, focused on AI-powered healthcare initiatives and pharmacy M&A across Africa. This entity is legally and operationally separate from XRP Healthcare LLC, which manages all XRPH token and digital asset activities. XRP Healthcare M&A Holding Inc. does not issue, control, or benefit from the XRPH token. For digital asset information, visit www.xrphtoken.com..
Oct 2, 2025
XRP Healthcare has already made history as the first healthcare platform on the XRP Ledger and the first to integrate AI within the XRPL ecosystem. These milestones established its reputation as a true disruptor—bridging digital assets, real-world healthcare, and breakthrough innovation.
In July 2025, XRP Healthcare M&A Holding Inc. issued a corporate structure clarification ahead of its proposed TSXV Qualifying Transaction. The update confirmed that its pharmacy acquisitions and AI-driven healthcare operations are fully independent of the XRPL token ecosystem.
Read the announcement here
This distinction highlights two strategic pillars: XRPL and token innovation reflect XRP Healthcare’s digital origins, while the M&A and AI model drives healthcare transformation and supports the upcoming TSXV listing.
Africa’s private healthcare sector is valued at $259 billion, yet fragmentation limits its potential. Independent pharmacies and clinics often work in silos, creating inefficiencies and restricting access for patients.
XRP Healthcare created its M&A Holding Company to unify providers and build a scalable, connected ecosystem.
In March 2025, the company completed its first acquisition: Pharma Ville, a Ugandan pharmacy chain that includes:
Five wholesale centers and two retail outlets
60 registered products, with 18 ready for commercialization and 70 more in the regulatory pipeline
Partnerships with eight global suppliers
Integration with Uganda’s National Medical Stores (NMS) and Joint Medical Stores (JMS)
This acquisition established a foundation for national and regional expansion.
Alongside consolidation, XRP Healthcare launched Africa’s first HIPAA-grade AI health app. Unlike blockchain, this initiative focuses directly on patient care. Key features include:
On-device encryption → protecting personal health data
AI-powered prescription scanning → verifying and managing medicines instantly
Image recognition tools → supporting safe self-care
Multilingual and voice support → increasing accessibility and breaking literacy barriers
The market opportunity is huge. Globally, the AI in healthcare market will grow from USD 22.45 billion in 2023 to USD 208.2 billion by 2030 at a CAGR of 37.5%. In the Middle East and Africa, it will rise from USD 193 million to USD 1.47 billion during the same period.
XRP Healthcare’s strength lies in combining physical infrastructure with digital innovation:
M&A consolidation builds pharmacy networks, strengthens supply chains, and improves efficiency.
AI solutions extend these networks digitally, making services accessible directly to patients.
Together, they form a healthcare system that is trusted, efficient, and scalable.
In July 2025, XRP Healthcare M&A Holding Inc. signed a Definitive Agreement with AAJ Capital 3 Corp. for a proposed listing on the TSX Venture Exchange (TSXV).
This agreement validates the M&A + AI model and opens the door for international investors. Importantly, the TSXV listing covers only the M&A and AI business, not the XRPL token ecosystem.
XRP Healthcare operates with two complementary innovation pillars:
On XRPL → the first healthcare platform and the first AI integration in its ecosystem.
In real-world healthcare → the first African healthcare consolidator preparing for public markets.
By bridging digital assets, AI, and physical healthcare infrastructure, XRP Healthcare is shaping a healthcare system that is connected, accessible, and future-ready.
This blog may contain “forward-looking information” or “forward-looking statements.” These involve risks and uncertainties that could cause actual results to differ. Completion of the proposed TSXV listing depends on regulatory approval and other conditions.